Tampere University of Technology

TUTCRIS Research Portal

In vitro characterization of alkylaminophenols-induced cell death

Research output: Contribution to journalArticleScientificpeer-review

Standard

In vitro characterization of alkylaminophenols-induced cell death. / Doan, Phuong; Anufrieva, Olga; Yli-Harja, Olli; Kandhavelu, Meenakshisundaram.

In: European Journal of Pharmacology, Vol. 820, 02.2018, p. 229-234.

Research output: Contribution to journalArticleScientificpeer-review

Harvard

APA

Vancouver

Author

Doan, Phuong ; Anufrieva, Olga ; Yli-Harja, Olli ; Kandhavelu, Meenakshisundaram. / In vitro characterization of alkylaminophenols-induced cell death. In: European Journal of Pharmacology. 2018 ; Vol. 820. pp. 229-234.

Bibtex - Download

@article{131680a6fe2544e1a942771a82587bd2,
title = "In vitro characterization of alkylaminophenols-induced cell death",
abstract = "Alkylaminophenols are synthetic derivatives well known for their anticancer activity. In the previous studies, we described the activity of the series of Alkylaminophenols derivatives and their ability to induce cell death for many cancer cell lines. However, temporal heterogeneity in cell death induced by lead compounds, N-(2-hydroxy-5-nitrophenyl (4'-methylphenyl) methyl) indoline (Compound I) and 2-((3,4-dihydroquinolin-1(2H)-yl) (4-methoxyphenyl) methyl) phenol (Compound II), has never been tested on osteosarcoma cells (U2OS). Here, we address the level of cell-to-cell heterogeneity by examine whether differences in the type of compounds could influence its effects on cell death of U2OS. Here, we applied imaging, computational methods and biochemical methods to study heterogeneity, apoptosis, reactive oxygen species and caspase. Our results demonstrate that the Hill coefficient of dose-response curve of Compound II is greater than compound I in treated U2OS cells. Both Compounds trigger not only apoptotic cell death but also necro-apoptotic and necrotic cell death. The percentage of these sub-populations varies depending on compounds in which greater variance is induced by compound II than Compound I. We also identified the accumulation of compounds-induced reactive oxygen species during the treatment. This resulted in caspase 3/7 activation in turn induced apoptosis. In summary, the screening of Compound I and II molecules for heterogeneity, apoptosis, reactive oxygen species and caspase has identified compound II as promising anti-osteosarcoma cancer agent. Compound II could be a promising lead compound for future antitumor agent development.",
author = "Phuong Doan and Olga Anufrieva and Olli Yli-Harja and Meenakshisundaram Kandhavelu",
note = "INT=tut-bmt,{"}Anufrieva, Olga{"}",
year = "2018",
month = "2",
doi = "10.1016/j.ejphar.2017.12.049",
language = "English",
volume = "820",
pages = "229--234",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - In vitro characterization of alkylaminophenols-induced cell death

AU - Doan, Phuong

AU - Anufrieva, Olga

AU - Yli-Harja, Olli

AU - Kandhavelu, Meenakshisundaram

N1 - INT=tut-bmt,"Anufrieva, Olga"

PY - 2018/2

Y1 - 2018/2

N2 - Alkylaminophenols are synthetic derivatives well known for their anticancer activity. In the previous studies, we described the activity of the series of Alkylaminophenols derivatives and their ability to induce cell death for many cancer cell lines. However, temporal heterogeneity in cell death induced by lead compounds, N-(2-hydroxy-5-nitrophenyl (4'-methylphenyl) methyl) indoline (Compound I) and 2-((3,4-dihydroquinolin-1(2H)-yl) (4-methoxyphenyl) methyl) phenol (Compound II), has never been tested on osteosarcoma cells (U2OS). Here, we address the level of cell-to-cell heterogeneity by examine whether differences in the type of compounds could influence its effects on cell death of U2OS. Here, we applied imaging, computational methods and biochemical methods to study heterogeneity, apoptosis, reactive oxygen species and caspase. Our results demonstrate that the Hill coefficient of dose-response curve of Compound II is greater than compound I in treated U2OS cells. Both Compounds trigger not only apoptotic cell death but also necro-apoptotic and necrotic cell death. The percentage of these sub-populations varies depending on compounds in which greater variance is induced by compound II than Compound I. We also identified the accumulation of compounds-induced reactive oxygen species during the treatment. This resulted in caspase 3/7 activation in turn induced apoptosis. In summary, the screening of Compound I and II molecules for heterogeneity, apoptosis, reactive oxygen species and caspase has identified compound II as promising anti-osteosarcoma cancer agent. Compound II could be a promising lead compound for future antitumor agent development.

AB - Alkylaminophenols are synthetic derivatives well known for their anticancer activity. In the previous studies, we described the activity of the series of Alkylaminophenols derivatives and their ability to induce cell death for many cancer cell lines. However, temporal heterogeneity in cell death induced by lead compounds, N-(2-hydroxy-5-nitrophenyl (4'-methylphenyl) methyl) indoline (Compound I) and 2-((3,4-dihydroquinolin-1(2H)-yl) (4-methoxyphenyl) methyl) phenol (Compound II), has never been tested on osteosarcoma cells (U2OS). Here, we address the level of cell-to-cell heterogeneity by examine whether differences in the type of compounds could influence its effects on cell death of U2OS. Here, we applied imaging, computational methods and biochemical methods to study heterogeneity, apoptosis, reactive oxygen species and caspase. Our results demonstrate that the Hill coefficient of dose-response curve of Compound II is greater than compound I in treated U2OS cells. Both Compounds trigger not only apoptotic cell death but also necro-apoptotic and necrotic cell death. The percentage of these sub-populations varies depending on compounds in which greater variance is induced by compound II than Compound I. We also identified the accumulation of compounds-induced reactive oxygen species during the treatment. This resulted in caspase 3/7 activation in turn induced apoptosis. In summary, the screening of Compound I and II molecules for heterogeneity, apoptosis, reactive oxygen species and caspase has identified compound II as promising anti-osteosarcoma cancer agent. Compound II could be a promising lead compound for future antitumor agent development.

U2 - 10.1016/j.ejphar.2017.12.049

DO - 10.1016/j.ejphar.2017.12.049

M3 - Article

VL - 820

SP - 229

EP - 234

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -